Prognosis of Interval Distant Metastases After Neoadjuvant Chemoradiotherapy for Esophageal Cancer-Reference-Cited by-同舟云学术

Prognosis of Interval Distant Metastases After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Published:2022-02 Issue:2 Volume:113 Page:482-490
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Kroese Tiuri E.,Dijksterhuis Willemieke P.M.,van Rossum Peter S.N.,Verhoeven Rob H.A.,Mook Stella,Haj Mohammad Nadia,Hulshof Maarten C.C. M.,van Berge Henegouwen Mark I.,van Oijen Martijn G.H.,Ruurda Jelle P.,van Laarhoven Hanneke W.M.,van Hillegersberg Richard

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference23 articles.

1. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Lordick;Ann Oncol,2016

2. The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction;Little;Ann Thorac Surg,2014

3. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

4. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

5. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN Clinical Practice Guidelines in Oncology;Ajani;J Natl Compr Cancer Netw,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interval Metastases After Neoadjuvant Chemoradiotherapy for Patients with Locally Advanced Esophageal Cancer: A Multicenter Observational Cohort Study;Annals of Surgical Oncology;2024-07-27

2. Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer;British Journal of Surgery;2022-08-23

3. Treatment patterns and survival in advanced unresectable esophageal squamous cell cancer: A population‐based study;Cancer Science;2022-01-25

4. A population-based study in synchronous versus metachronous metastatic esophagogastric adenocarcinoma;Therapeutic Advances in Medical Oncology;2022-01